List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 317 studies with search of: Efavirenz OR Sustiva [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Sustiva Levels With Use of a Gel Capsule
Conditions: HIV;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Over-encapsulated efavirenz
2 Unknown † Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
Conditions: Sleep Disorders;   HIV Infections
Interventions: Drug: Raltegravir for the first 2 weeks;   Drug: Efavirenz for the last 2 weeks;   Drug: Efavirenz for the first 2 weeks;   Drug: Raltegravir for the last 2 weeks
3 Active, not recruiting Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
4 Active, not recruiting Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
Condition: HIV Infections
Interventions: Drug: Viread (tenofovir disoproxil fumarate);   Drug: Sustiva (Efavirenz);   Drug: Epivir (Lamivudine);   Drug: Zerit (Stavudine)
5 Completed Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: nevirapine
6 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
7 Recruiting The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1
Condition: HIV Infection
Intervention: Drug: Efavirenz
8 Completed A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen
Condition: HIV Infections
Intervention: Drug: Atazanvir/ritonavir + efavirenz
9 Recruiting Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.
Condition: HIV Infections
Intervention: Drug: Efavirenz
10 Unknown † Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Condition: HIV Infection
Interventions: Drug: atazanavir arm;   Drug: efavirenz
11 Unknown † Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: First-line Antiretroviral Therapy
12 Completed
Has Results 		A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Conditions: HIV Infection;   HIV;   Acquired Immunodeficiency Syndrome
Interventions: Drug: etravirine (ETR, TMC125);   Drug: efavirenz (EFV)
13 Completed
Has Results 		Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: FTC/TDF;   Drug: FTC/TDF/EFV;   Drug: Lamivudine/zidovudine
14 Completed
Has Results 		Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment
Conditions: HIV Infections;   Hepatic Impairment
Intervention: Drug: efavirenz containing antiretroviral regimen
15 Completed Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
Conditions: HIV-1 Infection;   HIV Infection
Intervention: Drug: Efavirenz
16 Recruiting Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
17 Active, not recruiting
Has Results 		A Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA
Condition: HIV Infections
Interventions: Drug: MK0518;   Drug: Comparator: efavirenz;   Drug: Comparator: Truvada;   Drug: Comparator: Placebo to MK0518;   Drug: Comparator: Placebo to efavirenz
18 Recruiting The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)
Condition: HIV Infection
Intervention: Drug: Efavirenz
19 Unknown † Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: efavirenz
20 Withdrawn Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Condition: HIV-1 Infections
Interventions: Drug: TDF/FTC Once-Daily + Raltegravir 400 mg Orally Twice-Daily;   Drug: TDF/FTC + Efavirenz (Atripla) Once-Daily

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services